Medpace
MEDP
86 hedge funds and large institutions have $204M invested in Medpace in 2017 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 18 reducing their positions, and 12 closing their positions.
106% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 18
42% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 12
12% more capital invested
Capital invested by funds: $183M → $204M (+$21.1M)
5% more funds holding
Funds holding: 82 → 86 (+4)
0.72% more ownership
Funds ownership: 15.49% → 16.2% (+0.72%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$8.39M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$5.97M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$5.11M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.27M |
| 5 |
Millennium Management
New York
|
+$2.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$24.6M |
| 2 |
CLM
ClearBridge LLC (Maryland)
Baltimore,
Maryland
|
-$9.68M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.48M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$1.32M |
| 5 |
SIP
Stoneridge Investment Partners
Radnor,
Pennsylvania
|
-$778K |
MEDP Hedge Fund Activity: Q3 2017 in Review
86 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q3 2017, worth a combined $204M — up 12% from $183M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new MEDP positions and 12 closed out — a net gain of 5 holders — while 37 added to existing stakes and 18 trimmed.
The largest buyer was Redmile Group, adding an estimated $8.39M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $24.6M sold.
- 86 institutional investors held Medpace (MEDP) as of Q3 2017, up from 82 in Q2 2017.
- Funds reported $204M of Medpace stock for Q3 2017, up 12% quarter-over-quarter.
- 17 funds opened new Medpace positions in Q3 2017 and 12 closed out, a net change of +5 holders.
- The largest Medpace buyer in Q3 2017 was Redmile Group, an estimated $8.39M added.
- The largest Medpace seller in Q3 2017 was Adage Capital Partners, an estimated $24.6M sold.
Based on aggregated 13F filings for Q3 2017.